VAXIMM Company
VAXIMM is a vaccine company offers VXM01 targeting tumor vasculature.
Technology:
DNA
Industry:
DNA
Headquarters:
Basel, Basel-Stadt, Switzerland
Founded Date:
2008-01-01
Employees Number:
1-10
Investors Number:
4
Total Funding:
32500000
Estimated Revenue:
Less than $1M
Last Funding Date:
2012-10-02
Last Funding Type:
Grant
Register and Claim Ownership